Inhibition of matrix metalloproteinase-1 activity by the soybean Bowman–Birk inhibitor

被引：0
|
作者：
Jack N. Losso
Cate N. Munene
Rishipal R. Bansode
Hiba A. Bawadi
机构：
[1] Louisiana State University Agricultural Center,Food Protein Biotechnology Laboratory, Department of Food Science
来源：
Biotechnology Letters | 2004年 / 26卷
关键词：
angiogenesis; heparin-enhanced zymography; matrix metalloproteinase-1; quenched fluorescence substrate hydrolysis; soybean Bowman–Birk inhibitor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Inductively coupled plasma analysis of soybean Bowman–Birk inhibitor (BBI) indicated that BBI was a metalloprotein which contained magnesium, calcium, and zinc at 0.40, 0.43 and 0.008 atom/mol BBI, respectively. Heparin-enhanced gelatin zymography, quenched fluorescence substrate hydrolysis analysis, and the Biotrak assay of the interaction of BBI with the matrix metalloproteinase-1 (MMP-1) demonstrated that demineralized BBI at 30 nm inhibited MMP-1 activity whereas mineralized BBI was inhibitory at 115 nm.
引用
收藏
页码：901 / 905
页数：4
相关论文
共 50 条
  • [31] Soybean Bowman-Birk inhibitor conjugates with clinical dextran. Synthesis and antiproteolytic activity
    Gladysheva, I.P.
    Moroz, N.A.
    Papisova, A.I.
    Larionova, N.I.
    Biokhimiya, 2001, 66 (04): : 474 - 480
  • [32] Association of matrix metalloproteinase-1, matrix metalloproteinase-9, tissue inhibitor of matrix metalloproteinase-1, and interleukin-6 with epicardial and myocardial perfusion
    Tanindi, Asli
    Sahinarslan, Asife
    Elbeg, Sehri
    Cemri, Mustafa
    CORONARY ARTERY DISEASE, 2011, 22 (04) : 253 - 258
  • [33] Soybean Bowman-Birk inhibitor conjugates with clinical dextran. Synthesis and antiproteolytic activity
    Gladysheva, IP
    Moroz, NA
    Papisova, AI
    Larionova, NI
    BIOCHEMISTRY-MOSCOW, 2001, 66 (04) : 384 - 389
  • [34] Modulation of matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 in sepsis
    Maitra, Subir R.
    Jacob, Asha
    Zhou, Mian
    Wang, Ping
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2010, 3 (03): : 180 - 185
  • [35] Matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 in multiple sclerosis
    Boz, Cavit
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2006, 108 (06) : 618 - 618
  • [36] Inhibition of Matrix Metalloproteinase-1 by Dichloromethylene Bisphosphonate (Clodronate)
    O. Teronen
    Y. T. Konttinen
    C. Lindqvist
    T. Salo
    T. Ingman
    A. Lauhio
    Y. Ding
    S. Santavirta
    H. Valleala
    T. Sorsa
    Calcified Tissue International, 1997, 61 : 59 - 61
  • [37] Effects of Disulfide Bond Reduction on the Conformation and Trypsin/Chymotrypsin Inhibitor Activity of Soybean Bowman-Birk Inhibitor
    He, Hui
    Li, Xingfei
    Kong, Xiangzhen
    Zhang, Caimeng
    Hua, Yufei
    Chen, Yeming
    JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2017, 65 (11) : 2461 - 2467
  • [38] Glomerular Protein Levels of Matrix Metalloproteinase-1 and Tissue Inhibitor of Metalloproteinase-1 Are Lower in Diabetic Subjects
    Cornish, Toby C.
    Bagnasco, Serena M.
    Macgregor, Anne M.
    Lu, Jie
    Selvin, Elizabeth
    Halushka, Marc K.
    JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 2009, 57 (11) : 995 - 1001
  • [39] Inhibition of matrix metalloproteinase-1 by dichloromethylene bisphosphonate (Clodronate)
    Teronen, O
    Konttinen, YT
    Lindqvist, C
    Salo, T
    Ingman, T
    Lauhio, A
    Ding, Y
    Santavirta, S
    Valleala, H
    Sorsa, T
    CALCIFIED TISSUE INTERNATIONAL, 1997, 61 (01) : 59 - 61
  • [40] Effect of psoriasis activity on metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in plasma and lesional scales
    Flisiak, I
    Porebski, P
    Chodynicka, B
    ACTA DERMATO-VENEREOLOGICA, 2006, 86 (01) : 17 - 21
12345